Vivid Dx

Discover Faster Diagnostics Today

Business Model
B2B
Total Funding
$15.0M
Last Round
$15.0M SeedJul 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Vivid Dx unites leading experts in spectroscopy and microbiology with seasoned diagnostics executives to deliver a category-defining platform. The company is developing a next-generation diagnostic platform that reads the biochemical fingerprint of single cells using Raman spectroscopy, detects sepsis-causing pathogens using a large, proprietary Raman spectra database, and accelerates detection through advanced Artificial Intelligence and Machine Learning — delivering broad pathogen ID in 30 minutes and phenotypic antimicrobial susceptibility testing (AST) in 3 hours, compared to 2+ days for traditional blood culture.

Summary

Vivid Dx is an Artificial Intelligence company. It has raised $15.0M in total across 1 round, most recently a $15.0M Seed round in Jul 2026. Investors include Oxford Science Enterprises and Jameel Investment Management Company.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedJul 2026
$15.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vivid Dx on Indexed.vc
<a href="https://indexed.vc/companies/vivid-dx"><img src="https://indexed.vc/api/badge/company/vivid-dx" alt="Vivid Dx on Indexed.vc" width="260" height="76" /></a>